Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
tadalafil and ambrisentan upfront combination therapy
Locations
1
United States
Johns Hopkins University
Baltimore, Maryland, United States
Start Date
January 1, 2010
Primary Completion Date
November 1, 2014
Completion Date
November 1, 2014
Last Updated
September 12, 2017
NCT06649110
NCT07218029
NCT06947460
NCT07413341
NCT04402086
NCT07295847
Lead Sponsor
Johns Hopkins University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions